ETHYL 8-BROMOIMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE, 95.0%, 1g

{[4-(difluoromethoxy)phenyl]methyl}(methyl)amine, 97%, 50mg

(2-Carboxyethyl)phenylphosphinic Acid>98.0%(HPLC)(T)25g

4-(4-Methoxybenzoyl)isoquinoline, 97.0%, 1g

2,2,2-trifluoroetanol, mínimo 99,8 %, para síntesis, 100 ml, envase de vidrio

2-Ethynyl-3-methoxypyridine, 97.0%, 250mg

3-methyl-6-(pyridin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 250mg

2-(Tert-butoxy)-5-fluoroaniline, 97%, 1g

4,7-Bis{4-[n,n-bis(4-formylphenyl)amino]phenyl}-2,1,3-benzothiadiazole, 98%, 250mg

Methyl 2-(piperidin-4-yloxy)acetate hydrochloride, 95.0%, 250mg

4-Amino-6-chloro-2-methoxypyrimidine, 95.0%, 1g

7-Bromo-3,4-dihydroquinoxalin-2(1H)-one, 95.0%, 250mg

(1H-Benzo[d]imidazol-2-yl)methanamine hydrochloride, 95.0%, 250mg